Schedule 13G/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

BSQUARE CORPORATION
(Name of Issuer)
Common Stock
(Title of Class of Securities)
11776U300
(CUSIP Number)
December 31, 2010
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     þ Rule 13d-1(c)

     o Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications:
Taylor H. Wilson, Esq.
Haynes and Boone, LLP
2323 Victory Avenue, Suite 700
Dallas, Texas 75219
(214) 651-5000
 
 


 

                     
CUSIP No.
 
11776U300 
 

 

           
1   NAMES OF REPORTING PERSONS
Palogic Capital Management, LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   164,000
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    164,000
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  164,000
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  1.6% (1)
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO/HC
(1) Based upon 10,279,671 shares of common stock outstanding as of October 31, 2010, as disclosed in the Form 10-Q for the quarter ended September 30, 2010 filed by the issuer with the U.S. Securities and Exchange Commission on November 12, 2010.


 

                     
CUSIP No.
 
11776U300 
 

 

           
1   NAMES OF REPORTING PERSONS
Palogic Value Fund, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   164,000
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    164,000
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  164,000
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  1.6% (1)
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN
(1) Based upon 10,279,671 shares of common stock outstanding as of October 31, 2010, as disclosed in the Form 10-Q for the quarter ended September 30, 2010 filed by the issuer with the U.S. Securities and Exchange Commission on November 12, 2010.


 

                     
CUSIP No.
 
11776U300 
 

 

           
1   NAMES OF REPORTING PERSONS
Palogic Value Management, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   164,000
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    164,000
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  164,000
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  1.6% (1)
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN/HC
(1) Based upon 10,279,671 shares of common stock outstanding as of October 31, 2010, as disclosed in the Form 10-Q for the quarter ended September 30, 2010 filed by the issuer with the U.S. Securities and Exchange Commission on November 12, 2010.


 

                     
CUSIP No.
 
11776U300 
 

 

           
1   NAMES OF REPORTING PERSONS
Ryan L. Vardeman
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   164,000
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    164,000
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  164,000
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  1.6%(1)
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN/HC
(1) Based upon 10,279,671 shares of common stock outstanding as of October 31, 2010, as disclosed in the Form 10-Q for the quarter ended September 30, 2010 filed by the issuer with the U.S. Securities and Exchange Commission on November 12, 2010.


 

Item 1.
  (a)  
Name of Issuer
BSQUARE CORPORATION
  (b)  
Address of Issuer’s Principal Executive Offices
110 110th Avenue NE, Suite 200, Bellevue, Washington 98004
Item 2.
  (a)  
Name of Person Filing
This statement is jointly filed by and on behalf of each of Palogic Capital Management, LLC, Palogic Value Fund, L.P., Palogic Value Management, L.P. and Ryan L. Vardeman. Palogic Value Fund is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management is the general partner of, and may be deemed to indirectly beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management is the general partner of, and may be deemed to indirectly beneficially own securities owned by, Palogic Value Management. Ryan Vardeman is the sole Member of, and may be deemed to indirectly beneficially own securities owned by, Palogic Capital Management.
Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Sections 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this statement.
  (b)  
Address of Principal Business Office or, if none, Residence
The address of the principal business office of each of the reporting persons is 1700 Pacific Avenue, Suite 4535, Dallas, Texas 75201.
  (c)  
Citizenship
See Item 4 on the cover page(s) hereto.
  (d)  
Title of Class of Securities
Common Stock
  (e)  
CUSIP Number
11776U300
Item 3.  
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:
  (a) o 
A Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
 
  (b) o  A Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
 
  (c) o  An insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
 
  (d) o  An investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

 


 

  (e) o  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
 
  (f) o  An employee benefit plan or endowment fund in accordance with §240.13d- 1(b)(1)(ii)(F);
 
  (g) o  A parent holding company or control person in accordance with §240.13d- 1(b)(1)(ii)(G);
 
  (h) o  A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
  (i) o  A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
 
  (j) o  A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
 
  (k) o  A group, in accordance with §240.13d-1(b)(1)(ii)(K).
Item 4.  
Ownership.
  (a)  
Amount beneficially owned: See Item 9 on the cover page(s) hereto.
 
  (b)  
Percent of class: See Item 11 on the cover page(s) hereto.
 
  (c)  
Number of shares as to which such person has:
  (i)  
Sole power to vote or to direct the vote: See Item 5 on the cover page(s) hereto.
 
  (ii)  
Shared power to vote or to direct the vote: See Item 6 on the cover page(s) hereto.
 
  (iii)  
Sole power to dispose or to direct the disposition of: See Item 7 on the cover page(s) hereto.
 
  (iv)  
Shared power to dispose or to direct the disposition of: See Item 8 on the cover page(s) hereto.
Item 5.  
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following þ.
Item 6.  
Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable
Item 7.  
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable

 

 


 

Item 8.  
Identification and Classification of Members of the Group
Not Applicable
Item 9.  
Notice of Dissolution of Group
Not Applicable
Item 10.  
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 


 

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
         
Date: February 2, 2011   PALOGIC VALUE FUND, L.P.
 
 
  By:   Palogic Value Management, L.P., its general partner  
       
         
  By:   Palogic Capital Management, LLC, its general partner  
         
     
  By:   /s/ Ryan L. Vardeman    
  Name:   Ryan L. Vardeman   
  Title:   Sole Member   
 
         
  PALOGIC VALUE MANAGEMENT, L.P.
 
 
  By:   Palogic Capital Management, LLC, its general partner  
         
     
  By:   /s/ Ryan L. Vardeman    
  Name:   Ryan L. Vardeman   
  Title:   Sole Member   
 
         
  PALOGIC CAPITAL MANAGEMENT, LLC
 
 
         
  By:   /s/ Ryan L. Vardeman    
  Name:   Ryan L. Vardeman   
  Title:   Sole Member   
 
         
     
  RYAN L. VARDEMAN
 
 
  /s/ Ryan L. Vardeman    
     
     

 

 


 

         
EXHIBIT INDEX
     
Exhibit   Description of Exhibit
 
99.1
  Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G relating to the common stock of the issuer filed June 16, 2010 by the reporting persons with the Securities and Exchange Commission)